SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-001789
Filing Date
2021-09-13
Accepted
2021-09-13 16:35:13
Documents
76
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rani-20210630.htm   iXBRL 10-Q 3051272
2 EX-31.1 rani-20210630ex31_1.htm EX-31.1 10119
3 EX-31.2 rani-20210630ex31_2.htm EX-31.2 10144
4 EX-32.1 rani-20210630ex32_1.htm EX-32.1 8030
  Complete submission text file 0000950170-21-001789.txt   10410312

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rani-20210630_def.xml EX-101.DEF 298084
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rani-20210630_pre.xml EX-101.PRE 410978
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rani-20210630_cal.xml EX-101.CAL 35241
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rani-20210630_lab.xml EX-101.LAB 495096
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rani-20210630.xsd EX-101.SCH 64761
10 EXTRACTED XBRL INSTANCE DOCUMENT rani-20210630_htm.xml XML 1981742
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40672 | Film No.: 211250090
SIC: 2834 Pharmaceutical Preparations